SFS
MRVI icon

Sunrise Financial Services’s Maravai LifeSciences MRVI Stock Holding History

Sunrise Financial Services’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-66
Closed -$187 – 625
2026
Q1 		$187 Buy
+66
New +$224 ﹤0.01% 594

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Sunrise Financial Services's MRVI Position: Q2 2026 in Review

Sunrise Financial Services sold out of Maravai LifeSciences (MRVI) in Q2 2026, closing a stake of 66 shares — an estimated $187 sold.

Sunrise Financial Services first reported a position in MRVI in Q1 2026 and held it in 1 quarter. The position peaked at $187 in Q1 2026. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Sunrise Financial Services reported no remaining Maravai LifeSciences position as of Q2 2026 after selling out during the quarter.
  • Sunrise Financial Services sold 66 Maravai LifeSciences shares in Q2 2026, an estimated $187.
  • Sunrise Financial Services first reported a position in Maravai LifeSciences in Q1 2026 and held it in 1 quarter.
  • Sunrise Financial Services's Maravai LifeSciences position peaked at $187 in Q1 2026.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Sunrise Financial Services's 13F filing for Q2 2026, filed 12 Aug 2026.